**Chart Analysis: Expenses as a Percentage of Revenue**

**Metric:** Expenses as a Percentage of Revenue, broken down by category (Cost of Revenue, Research & Development, Marketing & Sales, General & Administrative) across nine quarters from Q1'23 to Q1'25.

**Key Data Points and Values (Category % of Revenue, Total % of Revenue):**
*   **Q1'23:** CoR 21%, R&D 33%, M&S 11%, G&A 10%. Total 75%.
*   **Q2'23:** CoR 19%, R&D 29%, M&S 10%, G&A 13%. Total 71%.
*   **Q3'23:** CoR 18%, R&D 27%, M&S 8%, G&A 6%. Total 59%.
*   **Q4'23:** CoR 19%, R&D 26%, M&S 8%, G&A 6%. Total 59%.
*   **Q1'24:** CoR 18%, R&D 27%, M&S 7%, G&A 9%. Total 61%.
*   **Q2'24:** CoR 19%, R&D 27%, M&S 7%, G&A 9%. Total 62%.
*   **Q3'24:** CoR 18%, R&D 28%, M&S 7%, G&A 5%. Total 58%.
*   **Q4'24:** CoR 18%, R&D 25%, M&S 7%, G&A 2%. Total 52%.
*   **Q1'25:** CoR 18%, R&D 29%, M&S 7%, G&A 5%. Total 59%.

**Significant Trends:**
*   **Total Expenses:** Overall decline from 75% in Q1'23 to a low of 52% in Q4'24, then a rebound to 59% in Q1'25.
*   **Research & Development:** Decreased significantly from 33% (Q1'23) to 25% (Q4'24), then increased to 29% (Q1'25).
*   **General & Administrative:** Highly volatile, ranging from a high of 13% (Q2'23) to a low of 2% (Q4'24), ending at 5% (Q1'25).
*   **Marketing & Sales:** Declined from 11% (Q1'23) and stabilized around 7-8% from Q1'24 onwards.
*   **Cost of Revenue:** Relatively stable, mostly within 18-19% after an initial 21% in Q1'23.